Galena Biopharma Releases Q4 Report Amid SEC Investigation
March 08, 2015 at 11:57 AM EDT
Galena Biopharma (NASDAQ: GALE) reported fourth quarter and year-end 2014 results on March 5th. The biopharmaceutical company specializes in oncology drugs and saw significant advancements in NeuVax, a drug used to prevent recurring cancers in survivors.
